Pharmacological activity of peroral chitosan–insulin nanoparticles in diabetic rats
Authors:
- Tit Meng LimTLTit Meng Lim
- Lee-Yong LimLee-Yong Lim
- 1 April 2005
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 293 (1-2) , 271-280
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Formulation pH modulates the interaction of insulin with chitosan nanoparticlesJournal of Pharmaceutical Sciences, 2002
- Encapsulation of Hydrophilic and Lipophilic Drugs in PLGA Nanoparticles by the Nanoprecipitation MethodDrug Development and Industrial Pharmacy, 1999
- Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayersInternational Journal of Pharmaceutics, 1997
- Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitroJournal of Controlled Release, 1997
- Biologically erodable microspheres as potential oral drug delivery systemsNature, 1997
- Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in RatsJournal of Pharmacy and Pharmacology, 1994
- In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymersInternational Journal of Pharmaceutics, 1992
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989
- New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrierDiabetes, 1988
- Intestinal sugar transport in experimental diabetesDiabetes, 1981